Silence Therapeutics Plc ADR (SLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 79,562 | 101,121 | 91,766 | 99,577 | 35,245 |
| Marketable Securities | N/A | N/A | 6,420 | 13,978 | 14,756 |
| Receivables | 15,307 | 10,005 | 4,851 | 9,091 | 42,169 |
| Other current assets | 8,327 | 7,591 | 3,700 | 5,038 | 5,926 |
| TOTAL | $103,197 | $118,717 | $106,738 | $127,683 | $98,096 |
| Non-Current Assets | |||||
| PPE Net | 2,547 | 2,673 | 1,971 | 1,828 | 5,806 |
| Investments And Advances | 404 | 414 | 388 | 421 | 389 |
| Intangibles | 10,300 | 10,473 | 10,001 | 10,861 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 10,454 |
| TOTAL | $13,250 | $13,560 | $12,360 | $13,110 | $16,649 |
| Total Assets | $116,447 | $132,276 | $119,097 | $140,793 | $110,387 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,310 | 14,828 | 11,859 | 10,998 | 10,519 |
| Other current liabilities | 10,671 | 5,840 | 11,595 | 9,389 | 21,882 |
| TOTAL | $21,103 | $20,856 | $23,622 | $20,637 | $32,838 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 89,991 | 99,696 | 74,469 | 87,075 | 65,917 |
| TOTAL | $89,991 | $99,696 | $74,469 | $87,075 | $65,917 |
| Total Liabilities | $111,093 | $120,552 | $98,091 | $107,712 | $98,755 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 29,928 | N/A | N/A | N/A |
| Common Shares | 6,023 | 6,173 | 5,764 | 6,272 | 5,348 |
| Retained earnings | -309,481 | -306,601 | -274,198 | -284,708 | -236,532 |
| Other shareholders' equity | 2,172 | 2,119 | 2,291 | 2,469 | 2,848 |
| TOTAL | $5,354 | $11,724 | $21,006 | $33,082 | $11,632 |
| Total Liabilities And Equity | $116,447 | $132,276 | $119,097 | $140,793 | $110,387 |